Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Latest News about NTLA
< Previous 1 2 3 4 5 Next >
50 Stocks Moving In Friday's Mid-Day Session
TICKERS  AEM AEY AGFS AMN
category DDOG , AEY , Markets , and 57 more.
from Benzinga
If You Invested $100 in CRISPR Therapeutics' IPO, This Is How Much Money You'd Have Now
TICKERS  CRSP EDIT NTLA
category CRSP , Market News , EDIT , and 1 more.
from Motley Fool
Here's Why CRISPR Stocks Fell in January
TICKERS  CRSP EDIT NTLA
category NTLA , EDIT , Market News , and 1 more.
from Motley Fool
68 Biggest Movers From Yesterday
TICKERS  ACMR AEMD AHPI AIMT
category DGLY , TSLA , EZPW , and 78 more.
from Benzinga
55 Stocks Moving In Tuesday's Mid-Day Session
TICKERS  ACMR AEMD AHPI ALB
category PGEN , MT , CTRA , and 64 more.
from Benzinga
146 Biotechnology Stocks Moving In Thursday's Session
TICKERS  ACIU ACOR ACRS ADXS
category TCRR , ADXS , INMB , and 151 more.
from Benzinga
These Gene-Editing Pioneers Are Making Bold Bets in Agriculture
TICKERS  BYND CLLS CLXT CRSP
category CLLS , DTIL , CLXT , and 5 more.
from Motley Fool
Is Intellia Therapeutics Stock a Buy?
TICKERS  CRSP EDIT NTLA PFE
category EDIT , NTLA , CRSP , and 2 more.
from Motley Fool
Why 2020 Should Be the Biggest Year Yet for CRISPR Gene-Editing Stocks
TICKERS  ABBV AGN BAYRY BMY
category BAYRY , AGN , REGN , and 9 more.
from Motley Fool
This Start-up Might Be the Next Gene Editing IPO
TICKERS  CRSP DTIL EDIT NTLA
category Market News , CRSP , DTIL , and 2 more.
from Motley Fool
64 Biggest Movers From Yesterday
TICKERS  ACB ADMS ADRO AEY
category FBIO , Market News , SNDL , and 74 more.
from Benzinga
CRISPR vs. Gene Therapy Round 1: What Investors Need to Know
TICKERS  BLUE CRSP EDIT NTLA
category NVS , VRTX , EDIT , and 4 more.
from Motley Fool
Better Buy: Editas Medicine or Sangamo Therapeutics?
TICKERS  AGN ALNY BMRN BMY
category SNY , CRSP , ALNY , and 9 more.
from Motley Fool
More CRISPR Stock Catalysts Ahead
TICKERS  CRSP EDIT NTLA VRTX
category Market News , CRSP , VRTX , and 2 more.
from Motley Fool
77 Biggest Movers From Yesterday
TICKERS  AEYE AIRT APHA APLT
category ATNX , PPSI , ETNB , and 87 more.
from Benzinga
Here's Why CRISPR Stocks Are Soaring Today
TICKERS  CRSP EDIT NTLA VRTX
category VRTX , NTLA , EDIT , and 2 more.
from Motley Fool
51 Stocks Moving In Tuesday's Mid-Day Session
TICKERS  AEYE ASH ATNX BASI
category OGI , JT , JKS , and 59 more.
from Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
TICKERS  APDN AXNX CGC CSCO
category FLGT , WMT , REPL , and 37 more.
from Benzinga
Better Buy: CRISPR Therapeutics vs. Intellia Therapeutics
TICKERS  CRSP NTLA
category NTLA , CRSP , Market News
from Motley Fool
Benzinga's Top Upgrades, Downgrades For Npvember 1, 2019
TICKERS  AMED ANET AXNX BKNG
category CTVA , top upgrades , Market News , and 43 more.
from Benzinga
Intellia Therapeutics, Inc. (NTLA) Q3 2019 Earnings Call Transcript
TICKERS  NTLA
category NTLA , Market News
from Motley Fool
The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut
TICKERS  ABMD ADMP AGIO AGN
category BCRX , DCPH , BASI , and 50 more.
from Benzinga
There's Yet Another Gene Editing Technique, but It Has 1 Glaring Problem
TICKERS  CRSP DTIL EDIT NTLA
category CRSP , Market News , EDIT , and 3 more.
from Motley Fool
The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO
TICKERS  ABBV ABMD ABUS ADMS
category NURO , GOSS , ARPO , and 63 more.
from Benzinga
Stocks That Hit 52-Week Lows On Wednesday
TICKERS  AACS AAWW ABMD ABML
category PSO , ABMD , DFIHY , and 196 more.
from Benzinga
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
TICKERS  ABMD ABUS ACRS ADAP
category NTGN , IBB , KNSA , and 68 more.
from Benzinga
42 Biggest Movers From Yesterday
TICKERS  ABTX ADMS ADPT AMBA
category SRAX , Benzinga , ADMS , and 52 more.
from Benzinga
Forget Vertex Pharmaceuticals; CRISPR Therapeutics Is a Better Biotech Growth Stock
TICKERS  ABBV CRSP EDIT GILD
category GILD , ABBV , CRSP , and 5 more.
from Motley Fool
Is CRISPR Therapeutics a Buy?
TICKERS  CRSP EDIT GILD NTLA
category NVS , EDIT , NTLA , and 3 more.
from Motley Fool
CRISPR gene-editing technique set to push new boundaries
TICKERS  AGN CRSP EDIT NTLA
category NVS , ONCE , Health/Care , and 7 more.
from MarketWatch
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.